The concept and practical use of open-source, which will be summarily covered, has gone further than any person could have possibly imagined just twenty years ago. A thorough introduction to the concept of open source will be given. Drawing from the many analogies already proven to be successful in other fields, a compelling case will be made as to why open-source licensing systems would be more beneficial for society than traditional means of distributing goods and knowledge. The pharmaceutical industry is plagued with notoriously high research and development (R&D) costs, unreasonably long and arduous procedural requirements, no or little incentives to focus on developing drugs for rare and neglected diseases – all of which are problems which can be remedied by the concept and application of open-source, which offers the industry a suitable and proper way to meet its future needs. We explore the development and themes surrounding a number of open-source licensing systems and frameworks which have been proposed in the field of biotechnology and pharmaceuticals, with special attention paid to the issues of R&D and rare and neglected diseases, especially in the Global South.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The concept and practical use of open-source, which will be summarily covered, has gone further than any person could have possibly imagined just twenty years ago. A thorough introduction to the concept of open source will be given. Drawing from the many analogies already proven to be successful in other fields, a compelling case will be made as to why open-source licensing systems would be more beneficial for society than traditional means of distributing goods and knowledge. The pharmaceutical industry is plagued with notoriously high research and development (R&D) costs, unreasonably long and arduous procedural requirements, no or little incentives to focus on developing drugs for rare and neglected diseases - all of which are problems which can be remedied by the concept and application of open-source, which offers the industry a suitable and proper way to meet its future needs. We explore the development and themes surrounding a number of open-source licensing systems and frameworks which have been proposed in the field of biotechnology and pharmaceuticals, with special attention paid to the issues of R&D and rare and neglected diseases, especially in the Global South. 60 pp. Englisch. N° de réf. du vendeur 9783330342835
Quantité disponible : 2 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 60 pages. 8.66x5.91x0.14 inches. In Stock. N° de réf. du vendeur 3330342838
Quantité disponible : 1 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Balabanian GeorgeGeorge Balabanian is a lawyer, linguist, translator, philologist, and philosopher. He holds numerous academic degrees and is primarily a communicator of ideas - whether in economics, history, game design, multilingua. N° de réf. du vendeur 156197855
Quantité disponible : Plus de 20 disponibles
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The concept and practical use of open-source, which will be summarily covered, has gone further than any person could have possibly imagined just twenty years ago. A thorough introduction to the concept of open source will be given. Drawing from the many analogies already proven to be successful in other fields, a compelling case will be made as to why open-source licensing systems would be more beneficial for society than traditional means of distributing goods and knowledge. The pharmaceutical industry is plagued with notoriously high research and development (R&D) costs, unreasonably long and arduous procedural requirements, no or little incentives to focus on developing drugs for rare and neglected diseases - all of which are problems which can be remedied by the concept and application of open-source, which offers the industry a suitable and proper way to meet its future needs. We explore the development and themes surrounding a number of open-source licensing systems and frameworks which have been proposed in the field of biotechnology and pharmaceuticals, with special attention paid to the issues of R&D and rare and neglected diseases, especially in the Global South.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 60 pp. Englisch. N° de réf. du vendeur 9783330342835
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The concept and practical use of open-source, which will be summarily covered, has gone further than any person could have possibly imagined just twenty years ago. A thorough introduction to the concept of open source will be given. Drawing from the many analogies already proven to be successful in other fields, a compelling case will be made as to why open-source licensing systems would be more beneficial for society than traditional means of distributing goods and knowledge. The pharmaceutical industry is plagued with notoriously high research and development (R&D) costs, unreasonably long and arduous procedural requirements, no or little incentives to focus on developing drugs for rare and neglected diseases - all of which are problems which can be remedied by the concept and application of open-source, which offers the industry a suitable and proper way to meet its future needs. We explore the development and themes surrounding a number of open-source licensing systems and frameworks which have been proposed in the field of biotechnology and pharmaceuticals, with special attention paid to the issues of R&D and rare and neglected diseases, especially in the Global South. N° de réf. du vendeur 9783330342835
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Open Source Licensing in Biotechnology and Pharmaceuticals | George Balabanian | Taschenbuch | 60 S. | Englisch | 2017 | LAP LAMBERT Academic Publishing | EAN 9783330342835 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 109487028
Quantité disponible : 5 disponible(s)